$436 Million is the total value of Eagle Health Investments LP's 28 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 7.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ILMN | Buy | ILLUMINA INC | $40,677,000 | +85.2% | 213,201 | +79.0% | 9.34% | +82.3% |
IQV | Buy | IQVIA HLDGS INC | $36,209,000 | +32.3% | 199,895 | +58.5% | 8.31% | +30.3% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $32,369,000 | +48.6% | 161,716 | +8.3% | 7.43% | +46.2% |
UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $29,468,000 | -21.5% | 140,738 | -11.6% | 6.76% | -22.7% |
HUM | Sell | HUMANA INC | $28,670,000 | -23.6% | 59,091 | -26.3% | 6.58% | -24.8% |
NTRA | Buy | NATERA INC | $26,116,000 | +29.1% | 595,994 | +4.4% | 5.99% | +27.0% |
CANO | Sell | CANO HEALTH INC | $24,534,000 | +46.8% | 2,829,796 | -25.9% | 5.63% | +44.5% |
SGEN | Sell | SEAGEN INC | $23,932,000 | -48.5% | 174,902 | -33.4% | 5.49% | -49.3% |
ISRG | Buy | INTUITIVE SURGICAL INC | $22,798,000 | +73.3% | 121,630 | +85.6% | 5.23% | +70.6% |
DXCM | Buy | DEXCOM INC | $21,408,000 | +21.1% | 265,800 | +12.1% | 4.91% | +19.2% |
ARGX | ARGENX SEsponsored adr | $21,289,000 | -6.8% | 60,300 | 0.0% | 4.89% | -8.3% | |
AZN | Sell | ASTRAZENECA PLCsponsored adr | $20,728,000 | -18.1% | 377,965 | -1.3% | 4.76% | -19.4% |
OM | Buy | OUTSET MED INC | $19,721,000 | +30.2% | 1,237,990 | +21.5% | 4.53% | +28.2% |
INSP | Buy | INSPIRE MED SYS INC | $17,835,000 | +3.7% | 100,553 | +6.8% | 4.09% | +2.1% |
AMWL | Sell | AMERICAN WELL CORPcl a | $13,038,000 | -19.3% | 3,631,710 | -2.9% | 2.99% | -20.6% |
TNDM | New | TANDEM DIABETES CARE INC | $9,398,000 | – | 196,400 | +100.0% | 2.16% | – |
AGIO | Sell | AGIOS PHARMACEUTICALS INC | $9,324,000 | -27.0% | 329,713 | -42.8% | 2.14% | -28.2% |
ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $8,650,000 | -12.0% | 1,214,860 | 0.0% | 1.98% | -13.4% | |
GH | GUARDANT HEALTH INC | $8,180,000 | +33.4% | 151,960 | 0.0% | 1.88% | +31.4% | |
AXNX | Sell | AXONICS INC | $7,788,000 | -46.4% | 110,560 | -56.9% | 1.79% | -47.3% |
CMAX | CAREMAX INC | $5,068,000 | +95.3% | 714,755 | 0.0% | 1.16% | +92.2% | |
FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $2,962,000 | +62.3% | 368,411 | +40.9% | 0.68% | +60.0% |
TXG | Sell | 10X GENOMICS INC | $1,401,000 | -88.1% | 49,200 | -81.2% | 0.32% | -88.3% |
BEAM | BEAM THERAPEUTICS INC | $1,377,000 | +23.1% | 28,900 | 0.0% | 0.32% | +21.1% | |
ARVN | ARVINAS INC | $1,023,000 | +5.7% | 23,000 | 0.0% | 0.24% | +4.0% | |
LYEL | LYELL IMMUNOPHARMA INC | $733,000 | +12.4% | 100,000 | 0.0% | 0.17% | +10.5% | |
BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $547,000 | +38.8% | 23,500 | 0.0% | 0.13% | +37.0% | |
OLK | OLINK HLDG ABsponsored ads | $486,000 | -20.1% | 40,000 | 0.0% | 0.11% | -21.1% | |
BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -170,551 | -100.0% | -2.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
NATERA INC | 12 | Q3 2023 | 8.5% |
ARGENX SE | 12 | Q3 2023 | 7.0% |
DEXCOM INC | 12 | Q3 2023 | 5.7% |
OUTSET MED INC | 12 | Q3 2023 | 7.3% |
AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-10-27 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-10 |
13F-HR | 2021-10-20 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.